Dr. Reddy's Laboratories Ltd ADR (RDY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 03-2025 | 03-2024 | 03-2023 | 03-2022 | 03-2021 | |
| Sales | 3,811,000 | 3,350,000 | 2,992,000 | 2,826,000 | 2,594,000 |
| Cost of Goods | 1,581,000 | 1,387,000 | 1,296,000 | 1,325,000 | 1,185,000 |
| Gross Profit | 2,230,000 | 1,963,000 | 1,695,000 | 1,500,000 | 1,409,000 |
| Operating Expenses | 1,388,000 | 1,151,000 | 1,001,000 | 1,112,000 | 960,000 |
| Operating Income | 842,000 | 813,000 | 695,000 | 389,000 | 449,000 |
| Interest Expense | 33,000 | 21,000 | 17,000 | 13,000 | 13,000 |
| Other Income | 91,000 | 70,000 | 56,000 | 50,000 | -75,000 |
| Pre-tax Income | 900,000 | 862,000 | 734,000 | 426,000 | 361,000 |
| Income Tax | 229,000 | 194,000 | 186,000 | 115,000 | 125,000 |
| Net Income Continuous | 671,000 | 668,000 | 548,000 | 311,000 | 236,000 |
| Minority Interests | 8,000 | N/A | N/A | N/A | N/A |
| Net Income | $663,000 | $668,000 | $548,000 | $311,000 | $236,000 |
| EPS Basic Total Ops | 0.79 | 0.80 | 0.66 | 0.37 | 0.28 |
| EPS Basic Continuous Ops | 0.81 | 0.80 | 0.66 | 0.38 | 0.28 |
| EPS Diluted Total Ops | 0.79 | 0.80 | 0.66 | 0.37 | 0.30 |
| EPS Diluted Continuous Ops | 0.80 | 0.80 | 0.66 | 0.37 | 0.28 |
| EPS Diluted Before Non-Recurring Items | 0.79 | 0.80 | 0.66 | 0.47 | 0.40 |
| EBITDA(a) | $1,042,000 | $990,000 | $849,000 | $545,000 | $624,000 |